Company
Pierre Fabre
Pierre Fabre has 32 drugs tracked on RxWires: 2 post-market, 7 in Phase 3, 12 in Phase 2, 5 in Phase 1/2, 5 in Phase 1.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| 5-fluorouracil 4% (Tolak) | Post-Market | Actinic Keratoses |
| Ferrous sulphate | Post-Market | Fatigue |
| J022X ST | Phase 3 | Recurrent Upper-Respiratory Tract Infections |
| tabelecleucel | Phase 3 | Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD) |
| bortezomib (Velcade ®) | Phase 3 | Multiple Myeloma |
| vinflunine | Phase 3 | Malignant Neoplasm of Breast |
| F2695 | Phase 3 | Ischemic Stroke |
| Encorafenib and Binimetinib | Phase 3 | Melanoma |
| RV3391A | Phase 3 | Cortico Atrophy |
| Paclitaxel, vinorelbine, cisplatin | Phase 2 | NSCLC Stage IIIB |
| F17464 | Phase 2 | Schizophrenia |
| V0162 | Phase 2 | Asthma |
| Milnacipran | Phase 2 | Fibromyalgia Syndrome |
| Navelbine | Phase 2 | Carcinoma Breast Stage IV |
| Encorafenib | Phase 2 | BRAF V600E |
| EBC | Phase 2 | Colorectal Cancer |
| Encorafenib Oral Capsule + Cetuximab | Phase 2 | Colorectal Cancer |
| Arm B Vinorelbine (Navelbine oral) Capecitabine (Xeloda) | Phase 2 | Breast Cancer |
| V0018 | Phase 2 | Healthy Highly Dependant Smokers |
| propranolol gel | Phase 2 | Infantile Hemangioma |
| Vinorelbine | Phase 2 | Breast Cancer |
| VERT-002 | Phase 1/2 | Solid Tumor |
| Bronchodilatator | Phase 1/2 | Chronic Obstructive Pulmonary Disease |
| Durvalumab + Tremelimumab + metronomic Vinorelbine | Phase 1/2 | Advanced Solid Tumours |
| STX-241 | Phase 1/2 | Non-small Cell Lung Cancer (NSCLC) |
| STX-721/PFL-721 (Escalated) | Phase 1/2 | Non-Small Cell Lung Cancer |
| V0057 - A mg | Phase 1 | Healthy Volunteers |
| KIN-2787 | Phase 1 | Solid Tumor, Adult |
| Binimetinib 15 MG | Phase 1 | Melanoma |
| V0355 | Phase 1 | Iron Deficiency Anemia |
| W0180 | Phase 1 | Locally Advanced or Metastatic Solid Tumors |
| Keratolytic/Antifungal | Not Applicable | Onychomycosis |
Latest
No recent events.
Follow Pierre Fabre on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.